课题基金 / 基金详情

Developing Novel Therapeutic Targets for Heart Failure

Developing Novel Therapeutic Targets for Heart Failure
开发心力衰竭的新治疗靶点
批准号：
334655
负责人：
Liu Peter P
金额：
$38.25万
依托单位：
University of Ottawa Heart Institute
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-09-01 至 2020-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=334655&lang=en
关键词：
Aging Heart Failure Target Validation Therapy

项目摘要

项目成果

Liu Peter P的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Much of heart failure treatment today is still ineffective, leading to many dying patients and unnecessary suffering. We have developed a large scale protein discovery technology to facilitate the identification of novel causes of heart failure, and poss
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The COVID-R3ICSAB Study: COVID-19 Wide Impact: Research on the Risk and Resilience In Special Communities of Chinese, South Asian and Black Populations
COVID-19 Variant Supplement - Improving Outcomes in Individuals with COVID-19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial
COVID-19 Vaccine-Induced Inflammatory Heart Disease Prevalence Registry and Cohort Study (COVID-VIHPR)
Improving Outcomes in Individuals with COVID-19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial
海外基金